Specialty pharmaceutical co appoints Robert Rosen to its board

By Admin
A.P. Pharma Inc said it has appointed Robert Rosen to its board of directors, the news reports said. Kevin C Tang , A.P. Pharmas Chairman of the board...

A.P. Pharma Inc said it has appointed Robert Rosen to its board of directors, the news reports said.

Kevin C Tang , A.P. Pharma’s Chairman of the board said, “We are delighted that Robert has chosen to join the A.P. Pharma board. Robert’s particular expertise in commercializing oncology drugs will be instrumental, as we enter the commercialization phase with our lead product, APF530, for preventing both acute and delayed-on set chemotherapy-induced nausea and vomiting.” 

Mr. Rosen is the Managing Partner of Scotia Nordic LLC. He has also served as the global head of oncology at BayerHealthCare from 2005 to 2011, where he was responsible to develop the oncology business unit for regions including the Europe, America, Japan and Asia Pacific.

During his tenure at Bayer HealthCare, he also led the launch of Nexavar to treat renal cell carcinmoma and hepatocellular carcinoma.

From period, 2002-2005, Mr. Rosen was also the Vice President of the oncology business unit at Sanofi Synthelabo, where he was responsible to develop Sanofi’s U.S.oncology business and the launch of Eloxatin for colon cancer.  

A.P. Pharma also said that it has appointed Kevin C Tang as Chairman of the board and Paul Goddard, PH.D. and Gregory Turnbull has resigned from the board.

It is a specialty pharmaceutical company that develops products using its proprietary biochronomer polymer-based drug delivery platform.

 

Share

Featured Articles

McKinsey: Consumers Demand Data-driven Wellness Products

New McKinsey Future of Wellness survey shows that consumers demand data-driven wellness solutions to improve health, sleep, nutrition, fitness & longevity

SpaceX Starlink Launch Boost for Indonesia Healthcare

As SpaceX CEO Elon Musk helps launch new satellite in Indonesia, we look at how the Starlink programme is improving healthcare provision in remote areas

J&J Targets Supplier Sustainability to Cut Healthcare GHGs

Johnson & Johnson takes collaborative approach to tackling the problem of carbon emissions in the global healthcare supply chain

Walgreens to Sell Over-the-Counter Opioid Overdose Drug

Medical Devices & Pharma

McKinsey Health Institute: Focus on Health Insights Body

Digital Healthcare

AstraZeneca & Celonis Map out Digital Transformation

Technology & AI